Medicare AdvantageCoverageMedium impact
MA07.032a, Tumor Treating Fields
Independence Blue Cross·Oncology, Neurology, Neurosurgery·Medical Policy
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA07.032a for Tumor Treating Fields has been updated with changes effective January 1, 2026. This policy likely affects coverage, prior authorization, or billing requirements for tumor treating field therapy devices and services.
Action Required
By January 1, 2026: Billing team must review the complete MA07.032a policy at the provided URL to understand specific changes to tumor treating fields coverage, prior authorization requirements, or billing procedures. Update billing system and provider workflows accordingly based on the detailed policy content.